Non-Hodgkin's lymphoma (Q73671868)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286289%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

review article

1 reference

title

Non-Hodgkin's lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286289%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

A Shad

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286289%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

I Magrath

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286289%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 August 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286289%20AND%20SRC:MED&resulttype=core&format=json

Pediatric Clinics of North America

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286289%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286289%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286289%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

863-890

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286289%20AND%20SRC:MED&resulttype=core&format=json

Long-term follow-up of patients treated with COMP or LSA2L2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

American Burkitt's lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Antibody-directed enzyme/prodrug therapy (ADEPT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Leukemia versus lymphoma in children: a worthless question?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T-cell leukemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Cytogenetic studies on African Burkitt's lymphoma cell lines: t(8;14), t(2;8) and t(8;22) translocations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Management of pediatric non-Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: a pediatric oncology group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Terminal Deoxynucleotidyl Transferase in Non-Hodgkin's Lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Multiple cases of Burkitt's lymphoma and other neoplasms in families in the North Mara District of Tanzania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Mediastinal nonlymphoblastic lymphomas in children: a clinicopathologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Long-term remissions following one and two-dose chemotherapy for African lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Coding sequences of the tal-1 gene are disrupted by chromosome translocation in human T cell leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Towards a molecular understanding of T-cell differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Humanized antibodies for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

T-cell lymphoma and the virus-associated hemophagocytic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Serum total and isoenzyme lactate dehydrogenase activity in American Burkitt's lymphoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Integrated control of cell proliferation and cell death by the c-myc oncogene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Acute Tumor Lysis Syndrome in Hematologic Malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Alpha, beta and gamma T-cell receptor genes: rearrangements correlate with haematological phenotype in T cell leukaemias.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

[Treatment strategies in malignant non-Hodgkin lymphomas in childhood]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Phase II study of cytarabine and etoposide in children with refractory or relapsed non-Hodgkin's lymphoma: a study of the French Society of Pediatric Oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Treatment of advanced stage diffuse, small non-cleaved cell lymphoma in childhood: further experience with total therapy B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Binding and suppression of the Myc transcriptional activation domain by p107.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Bone marrow involvement in young patients with non-Hodgkin's lymphoma: the importance of multiple bone marrow samples for accurate staging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

CNS involvement in small noncleaved-cell lymphoma: is CNS disease per se a poor prognostic sign?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Anterior mediastinal masses: anesthesia hazards and other problems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Acute tumor lysis syndrome in patients with high-grade non-Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Immunoglobulin and T-cell receptor gene rearrangements in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma: dissociation between phenotype and genotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Nonlymphoblastic lymphoma in children--histology and stage-related response to therapy: a Pediatric Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Cell kinetics of African cases of Burkitt lymphoma. A preliminary report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Use of Epstein-Barr virus nuclear antigen-1 in targeted therapy of EBV-associated neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Multiple phenotypic consequences of the Ig/Myc translocation in B-cell-derived tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

The role of surgery in abdominal non-Hodgkin's lymphoma: experience from the Childrens Cancer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Recombinant alpha-2B interferon treatment for childhood T--lymphoblastic disease in relapse. A Pediatric Oncology Group Phase II study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Molecular characterization of the t(10;14) translocation breakpoints in T-cell acute lymphoblastic leukemia: further evidence for illegitimate physiological recombination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Prognostic factors in Burkitt's lymphoma importance of total tumor burden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Surgical Reduction of Tumour Bulk in Management of Abdominal Burkitt's Lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Common complications and emergencies associated with cancer and its therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

A t(8;14)(q24;q11) translocation in a T-cell leukemia (L1-ALL) with c-myc and TcR-alpha chain locus rearrangements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Molecular cloning of the breakpoint junction of a human chromosomal 8;14 translocation involving the T-cell receptor alpha-chain gene and sequences on the 3' side of MYC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Bowel perforation during initial treatment for childhood non-Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Results of the LMT81 protocol, a modified LSA2L2 protocol with high dose methotrexate, on 84 children with non-B-cell (lymphoblastic) lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Massive therapy and autologous bone marrow transplantation in pediatric and young adults Burkitt's lymphoma (30 courses on 28 patients: a 5-year experience).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage--a report of the Berlin-Frankfurt-Münster Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Successful treatment strategy for Ki-1 anaplastic large-cell lymphoma of childhood: a prospective analysis of 62 patients enrolled in three consecutive Berlin-Frankfurt-Munster group studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

The role of initial laparotomy and second-look surgery in the treatment of abdominal B-cell non-Hodgkin's lymphoma of childhood. A report of the BFM Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Molecular and cellular origins of B lymphocyte diversity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Clinical features and treatment outcome for children with CD30+ large-cell non-Hodgkin's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Jaw involvement in American Burkitt's Lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Central nervous system involvement in American Burkitt's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Ultrasound evaluation of american burkitt's lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Malignant lymphomas with band 8q24 chromosome abnormality: a morphologic continuum extending from Burkitt's to immunoblastic lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Histiocytic sarcoma (true histiocytic lymphoma): a clinicopathological study of 20 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Anaplastic large cell lymphoma (Ki-1+/CD30+) in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Long-term results of the APO protocol (vincristine, doxorubicin [adriamycin], and prednisone) for treatment of mediastinal lymphoblastic lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Non-Hodgkin's lymphomas in children. II. Treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

The human T cell receptor genes are targets for chromosomal abnormalities in T cell tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970534-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(05)70534-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9286289%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference